Zhongxiao Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhongxiao Fu has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Chia-Yi Kuan
Department of Neuroscience, Center for Brain Immunology and Glia (BIG), University of Virginia School of Medicine
3 shared publications Yu-Yo Sun
Institute of BioPharmaceutical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan
3 shared publicationsAden Weybright
Department of Neuroscience, Center for Brain Immunology and Glia, University of Virginia School of Medicine, Charlottesville, USA
2 shared publicationsB. Jill Venton
Department of Chemistry, University of Virginia, Charlottesville, USA
2 shared publicationsEmily Bian
Department of Neuroscience, Center for Brain Immunology and Glia, University of Virginia School of Medicine, Charlottesville, USA
2 shared publicationsKatia Sol-Church
Department of Pathology, School of Medicine, University of Virginia, Charlottesville, USA
2 shared publications
Latest Publications
- 8 July 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 221,p. e67544
Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Cerebral blood flow (CBF) regulation is crucial for maintaining cognitive functions, but its underlying mechanisms remain poorly understood. Investigating the cellular and molecular processes involved in this regulation requires a pharmacological approach that allows precise drug delivery into cerebral spinal fluid (CSF) while enabling real-time monitoring of cerebral blood flow dynamics. In this paper, we present a method for studying cerebral blood flow regulation in vivo by combining nanoinjector-based intracisternal magna (ICM) injection with laser speckle contrast imaging. The nanoliter injector-based ICM injection technique allows for precise drug delivery at a dynamic range from nL/min to µL/min. In our experiments, this approach significantly reduced the injection volume from the traditional 5-10 μL to just 1.5 μL, thereby maintaining normal intracranial pressure. When combined with laser speckle contrast imaging, we were able to monitor cerebral blood flow (CBF) dynamics in real time before, during, and after ICM injections. Using this method, we evaluated CBF changes in response to ICM injection of three different vasodilators: (S)-3,5-Dihydroxyphenylglycine (DHPG), acetylcholine, and adenosine. While all three vasodilators increased basal CBF, they had distinct effects on CBF dynamics. For instance, adenosine's impact was transient, whereas DHPG and acetylcholine produced long-lasting effects. With its unique advantages, this method represents a valuable addition to the toolbox of studying rodent CBF regulation in vivo.
- 8 July 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 221,p. e67544
Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Cerebral blood flow (CBF) regulation is crucial for maintaining cognitive functions, but its underlying mechanisms remain poorly understood. Investigating the cellular and molecular processes involved in this regulation requires a pharmacological approach that allows precise drug delivery into cerebral spinal fluid (CSF) while enabling real-time monitoring of cerebral blood flow dynamics. In this paper, we present a method for studying cerebral blood flow regulation in vivo by combining nanoinjector-based intracisternal magna (ICM) injection with laser speckle contrast imaging. The nanoliter injector-based ICM injection technique allows for precise drug delivery at a dynamic range from nL/min to µL/min. In our experiments, this approach significantly reduced the injection volume from the traditional 5-10 μL to just 1.5 μL, thereby maintaining normal intracranial pressure. When combined with laser speckle contrast imaging, we were able to monitor cerebral blood flow (CBF) dynamics in real time before, during, and after ICM injections. Using this method, we evaluated CBF changes in response to ICM injection of three different vasodilators: (S)-3,5-Dihydroxyphenylglycine (DHPG), acetylcholine, and adenosine. While all three vasodilators increased basal CBF, they had distinct effects on CBF dynamics. For instance, adenosine's impact was transient, whereas DHPG and acetylcholine produced long-lasting effects. With its unique advantages, this method represents a valuable addition to the toolbox of studying rodent CBF regulation in vivo.
- Open Access
- 5 March 2025
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 9 (5) , 716-729
A positron emission tomography tracer for the imaging of oxidative stress in the central nervous system
Reactive oxygen and nitrogen species (RONS) contribute to the pathogenesis of neurodegeneration, but the inability to detect RONS in vivo in the central nervous system has confounded the interpretation of results of clinical trials of antioxidants. Here we report the synthesis and characterization of a positron emission tomography (PET) probe, [18F]fluoroedaravone ([18F]FEDV), for the in vivo quantification of oxidative stress. Derived from the antioxidant edaravone, the probe can diffuse through the blood–brain barrier and is stable in human plasma. In mice, PET imaging with [18F]FEDV allowed for the detection of RONS after intrastriatal injection of sodium nitroprusside, in the middle cerebral artery after stroke by photothrombosis, and in brains with tauopathy. When using dynamic PET imaging coupled with parametric mapping, the sensitivity of [18F]FEDV-PET to RONS allowed for the detection of increased oxidative stress. [18F]FEDV-PET could be used to quantify RONS longitudinally in vivo and to assess the results of clinical studies of antioxidants.
- 5 March 2025
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 9 (5) , 716-729
Open AccessA positron emission tomography tracer for the imaging of oxidative stress in the central nervous system
Reactive oxygen and nitrogen species (RONS) contribute to the pathogenesis of neurodegeneration, but the inability to detect RONS in vivo in the central nervous system has confounded the interpretation of results of clinical trials of antioxidants. Here we report the synthesis and characterization of a positron emission tomography (PET) probe, [18F]fluoroedaravone ([18F]FEDV), for the in vivo quantification of oxidative stress. Derived from the antioxidant edaravone, the probe can diffuse through the blood–brain barrier and is stable in human plasma. In mice, PET imaging with [18F]FEDV allowed for the detection of RONS after intrastriatal injection of sodium nitroprusside, in the middle cerebral artery after stroke by photothrombosis, and in brains with tauopathy. When using dynamic PET imaging coupled with parametric mapping, the sensitivity of [18F]FEDV-PET to RONS allowed for the detection of increased oxidative stress. [18F]FEDV-PET could be used to quantify RONS longitudinally in vivo and to assess the results of clinical studies of antioxidants.
- Top Cited PapersOpen Access
- 22 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Microglia modulate the cerebrovascular reactivity through ectonucleotidase CD39
Microglia and the border-associated macrophages contribute to the modulation of cerebral blood flow, but the mechanisms have remained uncertain. Here, we show that microglia regulate the cerebral blood flow baseline and the responses to whisker stimulation or intra-cisternal magna injection of adenosine triphosphate, but not intra-cisternal magna injection of adenosine in mice model. Notably, microglia repopulation corrects these cerebral blood flow anomalies. The microglial-dependent regulation of cerebral blood flow requires the adenosine triphosphate-sensing P2RY12 receptor and ectonucleotidase CD39 that initiates the dephosphorylation of extracellular adenosine triphosphate into adenosine in both male and female mice. Pharmacological inhibition or CX3CR1-CreER-mediated deletion of CD39 mimics the cerebral blood flow anomalies in microglia-deficient mice and reduces the upsurges of extracellular adenosine following whisker stimulation. Together, these results suggest that the microglial CD39-initiated breakdown of extracellular adenosine triphosphate co-transmitter is an important step in neurovascular coupling and the regulation of cerebrovascular reactivity.
- 22 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Top Cited PapersOpen AccessMicroglia modulate the cerebrovascular reactivity through ectonucleotidase CD39
Microglia and the border-associated macrophages contribute to the modulation of cerebral blood flow, but the mechanisms have remained uncertain. Here, we show that microglia regulate the cerebral blood flow baseline and the responses to whisker stimulation or intra-cisternal magna injection of adenosine triphosphate, but not intra-cisternal magna injection of adenosine in mice model. Notably, microglia repopulation corrects these cerebral blood flow anomalies. The microglial-dependent regulation of cerebral blood flow requires the adenosine triphosphate-sensing P2RY12 receptor and ectonucleotidase CD39 that initiates the dephosphorylation of extracellular adenosine triphosphate into adenosine in both male and female mice. Pharmacological inhibition or CX3CR1-CreER-mediated deletion of CD39 mimics the cerebral blood flow anomalies in microglia-deficient mice and reduces the upsurges of extracellular adenosine following whisker stimulation. Together, these results suggest that the microglial CD39-initiated breakdown of extracellular adenosine triphosphate co-transmitter is an important step in neurovascular coupling and the regulation of cerebrovascular reactivity.
- Open Access
Microglia modulate cerebral blood flow and neurovascular coupling through ectonucleotidase CD39
Microglia and the border-associated macrophages (BAMs) contribute to the modulation of cerebral blood flow (CBF), but the mechanisms have remained ill-defined. Here, we show that microglia regulate the CBF baseline and upsurges after whisker stimulation or intracisternal magna injection of adenosine triphosphate (ATP). Genetic or pharmacological depletion of microglia reduces the activity-dependent hyperemia but not the cerebrovascular responses to adenosine stimulation. Notably, microglia repopulation corrects these CBF reactivity deficits. The microglial-dependent regulation of CBF requires the ATP-sensing P2ry12 receptor and the ectonucleotidase CD39 that initiates the breakdown of extracellular ATP. Pharmacological inhibition or microglia-specific deletion of CD39 simulates the CBF anomalies detected in microglia-deficient mice and reduces the rise of extracellular adenosine after whisker stimulation. Together, these results suggest that the microglial CD39-initiated conversion of extracellular ATP to adenosine is an important step in neurovascular coupling and the regulation of cerebrovascular reactivity.
Open AccessMicroglia modulate cerebral blood flow and neurovascular coupling through ectonucleotidase CD39
Microglia and the border-associated macrophages (BAMs) contribute to the modulation of cerebral blood flow (CBF), but the mechanisms have remained ill-defined. Here, we show that microglia regulate the CBF baseline and upsurges after whisker stimulation or intracisternal magna injection of adenosine triphosphate (ATP). Genetic or pharmacological depletion of microglia reduces the activity-dependent hyperemia but not the cerebrovascular responses to adenosine stimulation. Notably, microglia repopulation corrects these CBF reactivity deficits. The microglial-dependent regulation of CBF requires the ATP-sensing P2ry12 receptor and the ectonucleotidase CD39 that initiates the breakdown of extracellular ATP. Pharmacological inhibition or microglia-specific deletion of CD39 simulates the CBF anomalies detected in microglia-deficient mice and reduces the rise of extracellular adenosine after whisker stimulation. Together, these results suggest that the microglial CD39-initiated conversion of extracellular ATP to adenosine is an important step in neurovascular coupling and the regulation of cerebrovascular reactivity.
- Open Access
- 1 January 2021
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 9 (1) , 62
Clinical manifestations of blood cell parameters and inflammatory factors in 92 patients with COVID-19
Background: Although there are many COVID-19 case series studies, few studies report the relationship between variations in blood cell parameters and inflammatory factors and disease severity. This study aims to describe the dynamic trends in COVID-19 blood cell parameters and inflammatory factors. Methods: Ninety-two patients with confirmed COVID-19 at Jingzhou Central Hospital, Hubei Province, China, between January 23, 2020, and April 10, 2020, were enrolled. Epidemiological data, clinical information, and laboratory test results were collected and analyzed. Results: As patient age increased, disease severity increased (P9/L), but patients with a poor prognosis continued to have a low LYM#. Conclusions: CRP and LYM# showed strong correlation with disease progression, suggesting that these parameters could be used to monitor changes in patient condition.
- 1 January 2021
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 9 (1) , 62
Open AccessClinical manifestations of blood cell parameters and inflammatory factors in 92 patients with COVID-19
Background: Although there are many COVID-19 case series studies, few studies report the relationship between variations in blood cell parameters and inflammatory factors and disease severity. This study aims to describe the dynamic trends in COVID-19 blood cell parameters and inflammatory factors. Methods: Ninety-two patients with confirmed COVID-19 at Jingzhou Central Hospital, Hubei Province, China, between January 23, 2020, and April 10, 2020, were enrolled. Epidemiological data, clinical information, and laboratory test results were collected and analyzed. Results: As patient age increased, disease severity increased (P9/L), but patients with a poor prognosis continued to have a low LYM#. Conclusions: CRP and LYM# showed strong correlation with disease progression, suggesting that these parameters could be used to monitor changes in patient condition.